Brind.

Recordati held its Board of Directors meeting in Milan on July 30, 2025, as a licensing agreement strengthened its SPC business in Europe.

2 reports, 2 independent Updated Jul 29

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Recordati held its Board of Directors meeting in Milan on July 30, 2025, as a licensing agreement strengthened its SPC business in Europe.

Who's involved

What this event is mainly about

Recordati Europe

Keep exploring

The entities involved

Recordati
Italian pharmaceutical company

Nothing else this week.
Europe
terrestrial continent located in north-western Eurasia
- The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49

Coverage

Newest first; wire copies grouped

Jul 29yahoo.com
Jul 30GlobeNewswireRECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES IN THE FIRST HALF OF 2025 REVENUE +11.7%, EBITDA(1) +9.6%, ADJUSTED NET INCOME(2) +8.9% Consolidated net revenue of € 1,323.8 million in the first ha